GENE ONLINE|News &
Opinion
Blog

Drug Discovery
Eli Lilly and Aktis Oncology Partner to Advance Novel Radiopharmaceuticals
2024-05-22
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Nikon Strengthens Global Presence in Drug Discovery with New BioImaging Labs
2024-01-30
Sanofi Goes “All In” to Lead the AI Revolution in Pharmaceutical Industry
2023-06-18
Ginkgo and Boehringer Join Forces in a $406 Million Partnership to Uncover New Therapeutic Molecules
2023-05-11
Bayer Signs Up To Google Cloud To Boost Drug Discovery
2023-01-13
Boston’s Manifold Bio Secures $40M to Tackle Translational Obstacles
2022-07-15
Roe Reversal May Cause Downstream Issues in Repurposing Mifepristone
2022-06-27
Brain Freeze, Iceland Based Pharma Company Gets Funding for ADHD R&D
2022-06-24
Amylyx’s New ALS Drug Review Impeded as FDA Members Disagreed with Clinical Trial Results
2022-04-04
WSJ Health Forum 2022: Psychedelics Set to Take Center Stage in Mental Wellness
2022-03-24
Roche Looks for Peptide-Like Small Molecules with Prism BioLab, joining Merck, Eisai and Boehringer Ingelheim
2022-01-05
A New Study Reveals Viagra Could Decrease the Risk of Alzheimer’s Disease
2021-12-08
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
HitGen Ink Deal with Cambridge Molecular to Create a Deep Learning-Driven Drug Discovery Platform
2021-11-08
1 2
LATEST
Generative AI Makes its Debut in Smart Healthcare with NVIDIA Experts at the Helm
2024-10-04
TCELS’s Path to a Self-Sufficient Biotech Thailand: Entrepreneurs in Global Competitiveness, Raw Material Exports, and Cosmetic Innovations
2024-10-04
Lilly Invests $4.5B in Indiana Facility for In-House Clinical Manufacturing
2024-10-03
Can New GLP-1 Contenders Disrupt the Weight-Loss Giants, Lilly and Novo, in the Battle for Market Dominance?
2024-10-03
2024 Tang Prize Celebrates Revolutionary Biopharma Discoveries, a Nod to Game-Changing Diabetes and Obesity Treatments
2024-09-30
Eyes on Nvidia: A Strong Investment Prospect, Driving Billions in AI Development and Advanced Infrastructure
2024-09-30
Immunai and AstraZeneca’s $18 Million AI Collaboration to Transform Cancer Drug Development
2024-09-26
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
2024-10-28
BioFuture 2024
New York, U.S.A.
2024-10-30
AusBiotech 2024
Melbourne, Australia
2024-11-04
BIO-Europe 2024
Stockholm, Sweden
Scroll to Top